Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
YT-19 by Bristar Immunotech Biotechnology for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
YT-19 is under clinical development by Bristar Immunotech Biotechnology and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell...
Data Insights
YT-19 by China Immunotech for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
YT-19 is under clinical development by China Immunotech and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute...